Novel Biomarkers in Translational Medicine of Chronic and Autoimmune Diseases

Dear Colleagues,

Inflammation is a normal physiological defence against pathogen infection and tissue damage and quickly ends under normal circumstances. However, in many chronic conditions, the inflammatory response continues and leads to significant tissue/organ damage.

Chronic diseases are multifactorial diseases and considered a serious public health problem, accounting for about 60% of deaths worldwide according to the WHO. The immune system plays a central role in many processes involving chronic diseases and subsequently cancer. New therapies have been proposed with potential positive impacts for patients, minimising morbidity and mortality.

The aim of this Special Issue is to invite original research articles, notable clinical findings, and review articles that present and discuss the advancement of research and innovative therapies involving chronic diseases, the regulation of inflammation in the pathology and treatment of autoimmune diseases, the relationship between inflammation and cancer, the latest research about the immune system and chronic diseases, and advances in genetics and molecular diagnostics.

Dr. Umberto Basile
Prof. Dr. Ettore Domenico Capoluongo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.